(Q38329067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

title

Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

1 reference

hepatitis E virus

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Ying Gu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Sheng X Ge

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Shao W Li

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Zhi Q He

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Guo Y Huang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Hui Zhuang

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Mun H Ng

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Ning S Xia

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

language of work or name

English

0 references

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

number of pages

12

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

2881-2892

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

9 January 2020

1 reference

Acute hepatitis E by a new isolate acquired in the United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Prevalence of and risk factors for antibody to hepatitis E virus seroreactivity among blood donors in Northern California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

The sequence and phylogenetic analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis reported in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Identification of a novel variant of hepatitis E virus in Austria: sequence, phylogenetic and serological analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Partial sequence analysis of indigenous hepatitis E virus isolated in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Fulminant Hepatitis E in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Incidence and severity of viral hepatitis in pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Acute sporadic viral hepatitis in Ethiopia: causes, risk factors, and effects on pregnancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Long-term serological follow up and cross-challenge studies in rhesus monkeys experimentally infected with hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Preliminary evidence that a trpE-HEV fusion protein protects cynomolgus macaques against challenge with wild-type hepatitis E virus (HEV).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

A bacterially expressed peptide prevents experimental infection of primates by the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Successful passive and active immunization of cynomolgus monkeys against hepatitis E

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Highly efficient and simple methods for the preparation of peroxidase and active peroxidase-antibody conjugates for enzyme immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Evaluation of antibody-based and nucleic acid-based assays for diagnosis of hepatitis E virus infection in a rhesus monkey model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Virus receptors: implications for pathogenesis and the design of antiviral agents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Receptor-mediated activation of immunodeficiency viruses in viral fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

inferred from DOI database lookup

7 January 2021

based on heuristic

A mutation in VP4 defines a new step in the late stages of cell entry by poliovirus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2004.11.065

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2004.11.065

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15780737%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference